Clinical Trial Update: CHANCE - Candesartan in Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating candesartan in hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: UNKNOWN